CD44 and cholangiocarcinoma: Conversely, a large immunohistochemical study by Padthaisong et al. (2020) [19] of 178 CCA samples provided contrasting evidence: they found that elevated CD44 and CD44v6 expression are significantly associated with shorter recurrence-free and overall survival.